FAST for Children with Conduct Problems
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new approach to help children with conduct problems and elevated callous-unemotional (CU) traits, such as lack of empathy or guilt. It focuses on improving how these children recognize emotions, especially fear and sadness, which could lead to better behavior outcomes. The trial involves a unique training called Facial Affect Sensitivity Training (FAST) to address these emotional recognition issues. Children who exhibit CU traits and struggle with recognizing emotions might be suitable candidates. As an unphased trial, this study offers a unique opportunity for children to potentially improve emotional recognition and behavior.
Will I have to stop taking my current medications?
The trial requires that any psychotropic medications (drugs that affect mood, perception, or behavior) must be on a stable dosing schedule for 2 weeks before joining. So, you won't have to stop taking them, but they need to be stable.
What prior data suggests that this intervention is safe for children with conduct problems?
Research has shown that the Facial Affect Sensitivity Training (FAST) program is practical and addresses important issues in children with high callous-unemotional (CU) traits. A preliminary study indicated that children generally manage the program well, experiencing no major problems. While specific details about side effects aren't provided, the focus on practicality usually suggests that the program doesn't cause significant negative effects. As FAST continues to develop, ongoing studies will monitor its safety and effectiveness.12345
Why are researchers excited about this trial?
Researchers are excited about the FAST intervention for children with conduct problems because it targets facial affect sensitivity, a unique approach compared to traditional behavioral therapies. While most current treatments focus on modifying external behaviors through therapy or medication, FAST aims to improve how children perceive and interpret facial emotions, which could lead to better social interactions and reduced conduct issues. Additionally, this approach could complement existing treatments by addressing an underlying cognitive factor, potentially leading to more comprehensive care and improved outcomes for children with conduct problems.
What evidence suggests that this trial's treatments could be effective for conduct problems in children?
Research has shown that Facial Affect Sensitivity Training (FAST), which participants in this trial may receive, could benefit children with high callous-unemotional (CU) traits. Studies have found that FAST helps these children better recognize emotions, especially distress-related ones like fear and sadness. This is crucial because kids with CU traits often struggle to understand these emotions, leading to behavior problems. Early findings suggest that by improving emotion recognition, FAST might also help reduce CU traits themselves. This method trains the brain to better notice emotional signals, potentially improving social interactions and behavior. Meanwhile, another group in this trial will receive an implicit gaze training intervention as an active control to compare the effectiveness of FAST.12367
Who Is on the Research Team?
Bradley A White, PhD
Principal Investigator
University of Alabama at Birmingham
Are You a Good Fit for This Trial?
This trial is for children aged 6-11 with high callous-unemotional traits, which include a lack of empathy or guilt. They must have difficulty recognizing emotions on faces, an IQ score of at least 80, and stable psychotropic medication use if applicable. Children with bipolar disorder, autism, current therapy for CU traits or emotion recognition deficits are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
R61 Phase Treatment
Participants receive the FAST intervention to improve facial affect sensitivity in children with elevated CU traits.
R33 Phase Treatment
Replication of FAST target engagement with a new high-CU sample and evaluation of FAST intervention compared to an active control condition.
Follow-up
Participants are monitored for changes in CU traits and empathy measures after treatment.
What Are the Treatments Tested in This Trial?
Interventions
- Facial Affect Sensitivity Training (FAST)
- Implicit Gaze Training task (Active control condition)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama, Tuscaloosa
Lead Sponsor